Literature DB >> 34020621

Association between MTNR1B polymorphisms and obesity in African American: findings from the Jackson Heart Study.

Cynthia Tchio1,2, Solomon K Musani3, Alexander Quarshie4, Gianluca Tosini5,6.   

Abstract

BACKGROUND: Melatonin is a hormone that is secreted at night by the pineal gland. It exerts its function by binding to the MT1 and MT2 receptors, which are encoded by the MTNR1A and MTNR1B genes, respectively. Previous studies reveal that MTNR1B variants are associated with insulin secretion impairments and an increased body mass index (BMI) in individuals of European and Asian ancestries. Obesity is highly prevalent in the US and disproportionately affects African Americans. Here, we hypothesized that common single nucleotide polymorphisms (SNPs) imputed in 1000 Genomes in the MTNR1B gene are associated with adiposity in African American adult men and women and that the association is modified by insomnia.
METHODS: We used an additive genetic model to describe the association between the adiposity traits (BMI and waist circumference) and selected MTNR1B variants in 3,029 Jackson Heart Study participants, with an average age of 55.13 ± 12.84 years, and 62% were women. We regressed the adiposity measures on the estimated allelic or genotypic dosage at every selected SNP and adjusted for age, sex, population stratification, and insomnia. Thirty common SNPs, spanning the MTNR1B gene, with a minor allele frequency ≥ 5%, a call rate ≥ 90%, a Hardy-Weinberg equilibrium p value > 10-6, were available for the analysis.
RESULTS: The allele T of rs76371840 was associated with adiposity (OR = 1.47 [1.13-1.82]; PFDR-adjusted = 0.0499), and the allele A of rs8192552 showed a significant association with waist circumference (β = 0.023 ± 0.007; PFDR-adjusted = 0.0077) after correcting for multiple testing. When insomnia was included in the adiposity analysis model, the following four variants became significantly associated with adiposity: rs6483208; rs4388843; rs4601728; and rs12804291.
CONCLUSIONS: Our data indicate that polymorphisms in the MTNR1B gene are associated with obesity traits in African Americans. To the best of our knowledge, this is the first study to explore the effect of insomnia on the association between the circadian MTNR1B genetic variants and metabolic traits in an African American sample population. We observed that insomnia affected the association between the MTNR1B variants and adiposity.

Entities:  

Keywords:  Adiposity; African american; Body mass index; Insomnia; MTNR1B; Obesity; Waist circumference

Mesh:

Year:  2021        PMID: 34020621      PMCID: PMC8138980          DOI: 10.1186/s12920-021-00983-2

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


Background

Melatonin is a chronobiotic hormone that is synthesized by the pineal gland at night [1]. Melatonin is not stored within the pineal gland, but due to its lipophilic nature, it diffuses in the bloodstream, where it rapidly reaches target tissues. Melatonin’s function is exerted in a tissue-specific manner by binding to specific G-coupled protein receptors known as melatonin receptor type 1 (MT1) and melatonin receptor type 2 (MT2). These receptors are present in many tissues and organs [1, 2]. In humans, MT1 and MT2 are encoded by the MTNR1A and MTNR1B genes, respectively. Multiple studies demonstrate that melatonin is involved in regulating sleep, circadian rhythms, reproduction, and metabolic processes [3-5]. Polymorphisms in the MTNR1B gene have been linked to impairments in insulin secretion, fasting blood glucose (FBG) levels, and an increased body mass index (BMI) in individuals of European and Asian ancestry [6-9]. There are various potential mechanisms by which polymorphisms in the MTNR1B gene might increase FBG levels. It has been reported that the common variant rs10830963, which increases MT2 signaling, might also be associated with an increased risk of developing type 2 diabetes (T2D) [9, 10]. Other studies in individuals of European ancestry show that rare variants in the MTNR1B gene result in reduced or absent MT2 signaling, which is also associated with an increased FBG level and an increased risk of developing T2D [11-13]. Obesity is defined as a BMI greater than 30, and it is a growing pandemic that affects 36.5% of US adults [14]. Obesity is prevalent across different ethnic groups, with African Americans having the highest age-adjusted rates [15]. Although African Americans have a higher prevalence of obesity [15] and the highest prevalence of short sleep duration and insomnia compared to other ethnicities [16-18], there are no documented studies on the influence of MTNR1B on adiposity or the effect of insomnia on this association. This study aimed to investigate whether selected common genetic variations in the MTNR1B gene reported in previous studies were associated with adiposity in a sample of African American individuals and whether those associations were modified by insomnia.

Results

Study population characteristics

The study population characteristics are displayed in Table 1. Of the available study sample, the average age was 55 years old, and 1871 (62%) were women. The participants had a mean BMI of 32 kg/m2, a mean waist circumference of 101 cm, and a total cholesterol of 198 mg/dL. Also, 679 (29%) participants had diabetes, and the study population had a mean fasting glucose of 100 mg/dL, a mean HbA1c percentage of 6, and a fasting insulin of 19 IU/mL. Additionally, 98 (5%) participants reported insomnia.
Table 1

Clinical characteristics of the study population

Participants (male /female)3029 (1149/1871)
Age (years)55.13 ± 12.84
Adiposity (yes/no)2450/578
BMI (kg/m2)32.02 ± 7.44
Waist circumference (cm)101.34 ± 16.31
Total cholesterol (mg/dL)198.42 ± 40.59
LDL (mg/dL)126.6 ± 36.6
HDL (mg/dL)51.25 ± 14.67
Type 2 diabetes (Yes/No)679/2336
Fasting plasma glucose (mg/dL)100.54 ± 33.71
Fasting insulin (IU/mL)18.75 ± 24.25
HOMA IR3.62 ± 2.32
HbA1c (%)6.00 ± 1.33
Nighttime sleep (h)6.43 ± 1.52
Insomnia (yes/no)98/1976
Clinical characteristics of the study population

The ASSOCIATION of MTNR1B SNPs with BMI and waist circumference

As shown in Table 2, multiple linear regression models identified sixteen MTNR1B variants that showed a nominally significant association (FDR p value ≤ 0.05) with continuous obesity traits (BMI and waist circumference). Fourteen MTNR1B SNPs were inversely and significantly associated with BMI. Ten of these remained significant after adjusting for multiple testing. For waist circumference, sixteen MTNR1B SNPs showed a significant inverse association, while rs8192552 showed a significant direct effect.
Table 2

The association of MTNR1B SNPs with BMI and waist circumference

BMIWaist circumference
SNPsBPA1A2MAFp valueFDR p valueBetaSE (Beta)p valueFDR p valueBetaSE (Beta)Type of Mutation
rs378163892980341TG0.4990.00410.0200−0.01580.00550.00060.0075−0.01400.0041Intronic
rs156244492982683AG0.4460.00560.0200−0.01530.00550.00070.0075−0.01380.00413'-UTR
rs1279265392982750AG0.4460.00560.0200−0.01530.00550.00080.0075−0.01380.00413'-UTR
rs819255292969796GA0.0940.04320.09250.01890.00940.00100.00770.02280.0069Missense
rs648320992976223CT0.2120.00250.0200−0.02010.00670.00200.0089−0.01530.0050Intronic
rs1229086092979012GA0.2240.00600.0200−0.01840.00670.00170.0089−0.01550.0049Intronic
rs712712892980510AG0.2270.00290.0200−0.01960.00660.00240.0089−0.01490.0049Intronic
rs648321092981429CT0.2270.00290.0200−0.01970.00660.00250.0089−0.01480.0049Intronic
rs6174713992981951AG0.2270.00300.0200−0.01960.00660.00270.0089−0.01470.0049Missense
rs1076557692973778GA0.4890.03320.0831−0.01170.00550.00380.0096−0.01170.0040Intronic
rs1102012792974394CA0.4950.00500.0200−0.01860.00670.00340.0096−0.01190.0041Intronic
rs1229240092979446GC0.2250.03940.0909−0.01120.00540.00380.0096−0.01430.0049Intronic
rs1227226892975633CG0.2520.01840.0501−0.01470.00630.00480.0111−0.01310.0046Intronic
rs713042492980527TC0.2660.00990.0298−0.01600.00620.00540.0116−0.01280.0046Intronic
rs1102012692973751GA0.1810.06060.1212−0.01360.00720.01650.0331−0.01290.0054Intronic
rs1102012592973378TG0.1710.08950.1679−0.01240.00730.02180.0409−0.01240.0054Intronic
rs648320892972678TG0.220.14460.2411−0.00960.00660.02870.0507−0.01070.0049Intronic

BMI for adjusted age, sex, and ancestry; Waist Circumference for adjusted age, sex, and ancestry. The associations' results are Beta, standard error (SE), and the corresponding adjusted False Discovery Rate (FDR) p value. A1 and A2 are reference allele and alternative allele; MAF is Minor Allele Frequency; BP is Base Pair

The association of MTNR1B SNPs with BMI and waist circumference BMI for adjusted age, sex, and ancestry; Waist Circumference for adjusted age, sex, and ancestry. The associations' results are Beta, standard error (SE), and the corresponding adjusted False Discovery Rate (FDR) p value. A1 and A2 are reference allele and alternative allele; MAF is Minor Allele Frequency; BP is Base Pair

Association between MTNR1B variants with adiposity adjusting for insomnia

A multiple logistic regression model identified sixteen MTNR1B variants with a significant association with adiposity (Table 3). After adjusting for insomnia, four new variants, not identified in our previous models, showed a nominally significant association (FDR p value ≤ 0.05) with adiposity (Table 3). Based on the functional annotation of the MTNR1B variants, only two of the variations were missense variants, and we identified variants in other regulatory regions. In the regulatory regions of the MTNR1B introns, two of the variants were in the 3 prime-untranslated region (3’-UTR).
Table 3

The Association between MTNR1B Variants and Adiposity adjusting for Insomnia

AdiposityAdiposity-Insomnia
SNPsBPA1A2MAFp valueFDRp valueORLCIUCIp valueFDRp valueORLCIUCIType of Mutation
rs1229086092979012GA0.22400.00420.02500.740.540.950.00120.00400.660.400.91Intronic
rs6174713992981951AG0.22700.00420.02500.740.540.950.00130.00400.660.410.92Missense
rs648321092981429CT0.22700.00430.02500.750.540.950.00130.00400.660.410.92Intronic
rs712712892980510AG0.22700.00440.02500.750.540.950.00130.00400.660.410.92Intronic
rs1229240092979446GC0.22500.00550.02500.750.550.950.00170.00470.670.410.92Intronic
rs648320992976223CT0.21200.00220.02500.730.520.930.00030.00250.620.360.88Intronic
rs713042492980527TC0.26600.01170.02810.790.600.970.00210.00530.700.460.93Intronic
rs1227226892975633CG0.25200.00750.02500.770.580.960.00070.00400.670.430.91Intronic
rs1279265392982750AG0.44600.01210.02810.810.640.970.08720.13130.830.621.043’-UTR
rs156244492982683AG0.44600.01220.02810.810.640.980.08750.13130.830.621.043’-UTR
rs1102012692973751GA0.18100.00600.02500.730.510.960.0000450.00120.560.270.84Intronic
rs1102012592973378TG0.17100.00700.02500.740.510.960.00010.00120.570.280.86Intronic
rs1227790492978680CT0.13700.01050.02810.730.480.970.01150.02030.680.380.98Intronic
rs11662562392971729GT0.09500.01800.03850.700.411.000.00120.00400.540.170.92Intronic
rs712976892980510GA0.08800.02020.04040.700.401.000.00330.00750.560.180.95Intronic
rs7637184092971529CT0.07400.02660.04991.481.131.820.04230.07051.541.121.96Intronic
rs648320892972678TG0.22000.02910.05140.800.601.000.00030.00250.630.380.89Intronic
rs438884392971820GA0.31100.23110.30150.900.721.080.00580.01230.730.500.95Intronic
rs460172892971992AG0.31300.24320.30400.900.721.080.00660.01320.730.510.96Intronic
rs1280429192972141CT0.26500.22030.30050.890.711.080.00920.01720.730.500.97Intronic

Adiposity for adjusted age, sex, and ancestry; Adiposity-Insomnia for Adiposity model with adjustment for Insomnia. The results of the associations are listed as Odds Ratio (OR) with the Lower and Upper Confidence Interval (LCI and UCI) and the corresponding adjusted False Discovery Rate (FDR) p value. A1 and A2 are reference allele and alternative allele; MAF is Minor Allele Frequency; BP is Base Pair

The Association between MTNR1B Variants and Adiposity adjusting for Insomnia Adiposity for adjusted age, sex, and ancestry; Adiposity-Insomnia for Adiposity model with adjustment for Insomnia. The results of the associations are listed as Odds Ratio (OR) with the Lower and Upper Confidence Interval (LCI and UCI) and the corresponding adjusted False Discovery Rate (FDR) p value. A1 and A2 are reference allele and alternative allele; MAF is Minor Allele Frequency; BP is Base Pair

Linkage disequilibrium

To understand the linkage disequilibrium (LD) around the suggestively or nominally significant MTNR1B variants, we generated an LD plot (Fig. 1). Three haplotypes were identified from the LD plot in the MTNR1B genes from the JHS cohort (Fig. 1). In haplotype block 1, all the variants showed a strong LD (D′ > 1) except for rs76371840. For block 2, all the variants were in strong LD. In haplotype block 3, most variants were in strong LD except rs7130424 & rs37816638 and rs7130424 & rs1562444 (D′ < 1).
Fig. 1

Linkage Disequilibrium Plot for SNPs in the MTNR1B gene. The value in each diamond is r2 between pairs of SNPs. The haploview standard color scheme, for LD color display with bright red (LOD ≥ 2 and D′ = 1), shades of pink/red (LOD ≥ 2 and D′ < 1), white (LOD < 2 and D′ < 1), and blue (LOD < 2 and D′ = 1). Haploview generated haplotypes blocks for SNPs in strong LD

Linkage Disequilibrium Plot for SNPs in the MTNR1B gene. The value in each diamond is r2 between pairs of SNPs. The haploview standard color scheme, for LD color display with bright red (LOD ≥ 2 and D′ = 1), shades of pink/red (LOD ≥ 2 and D′ < 1), white (LOD < 2 and D′ < 1), and blue (LOD < 2 and D′ = 1). Haploview generated haplotypes blocks for SNPs in strong LD

Discussion

In this study, we examined the associations of polymorphisms in MTNR1B with obesity traits in a sample of African Americans at JHS. Our principal findings revealed a significant association of rs8192552 with high waist circumference even after adjusting for multiple testing. Furthermore, the T allele of rs76371840 was associated with adiposity even after adjusting for insomnia in the regression model. We also observed four new variants (allele G of rs6483208, allele A of rs4388843, allele G of rs4601728, and allele T of rs12804291) that showed an effect on adiposity outcome after adjusting for insomnia. To the best of our knowledge, we are the first to report this association. Our results indicated a significant association of rs8192552 with high waist circumference. The variant rs8192552 is a missense variant that has been extensively studied in T2D and shows no association to T2D in European populations [19] and African American populations [20]. However, rs8192552 is significantly associated with BMI and waist circumference in French and Danish populations [19]. Elsewhere, rs8192552 did not show a significant association with BMI, as well as waist circumference [20, 21]. Andersson et al. [19] reported that the missense variant rs61747139 did not display a significant association with BMI and waist circumference. Allele G of rs61747139 has been reported to cause an amino acid change of lysine to arginine. This codon change could affect gene expression, leading to a defect in melatonin signaling pathways. Karamitri et al. [12] observed that rs61747139 decreased β-arrestin-2 recruitment, while rs8192552 did not. The β-arrestins desensitize G-protein-coupled receptors (e.g., MTNR1B) to prevent further stimulation of G proteins and the downstream signaling pathways [22]. The overstimulation of melatonin signaling by variant rs61747139 via β-arrestin-2 could lead to a downstream effect on markers involved in obesity. The pairwise variants rs12792653 and rs1562444 are associated with both BMI and waist circumference. These SNPs (rs12792653 and rs1562444) are in the 3’-UTR region of the mRNA that follows the stop codon, which contains regulatory regions essential for post-transcription regulation [23]. It also contains binding sites for regulatory elements, such as microRNAs, repressors proteins, and proteins that bind to AU-rich elements (ARE-BP), which are involved in either translation activation or repression [23, 24]. Thus, 3’-UTRs act as cis-regulators. Additionally, insomnia modified the association between the MTNR1B variants and adiposity because we observed four novel variants (rs6483208, rs4388843, rs4601728, and rs12804291) with a significant association with adiposity when we adjusted for insomnia. To date, few studies have investigated the association between the circadian-related gene variants with metabolic parameters [25-28]. Ollila et al. described the effect of insomnia on the association of MTNR1B variants on blood glucose [25]. Another study discussed the effect of diet and sleep on the association between circadian-related gene variants (MTNR1B, CLOCK, CRY, and NR1D1) and metabolic traits (fasting glucose, BMI, waist circumference, and HDL-cholesterol) [28]. Our study demonstrated that insomnia affected the association between MTNR1B variants and adiposity in an African American sample population. While these findings are insightful to the role of MTNR1B variants in African Americans, a few limitations are worth mentioning. Our main limitation is the small sample size relative to studies of different ethnic backgrounds. Our study needs to be replicated in a larger African American cohort. Another limitation is the use of BMI to assess adiposity instead of the overall body fat mass. Despite these limitations, our data produced associations that were similar to other studies.

Conclusions

In summary, we found a novel association between allele A of rs8192552 and high waist circumference. Also, allele T of rs76371840 showed an association with adiposity. Moreover, allele G of rs12792653 and allele G of rs1562444 in the 3’-UTR were associated with BMI and waist circumference. Additionally, when the data was adjusted for insomnia in the adiposity model, allele G of rs6483208, allele A of rs4388843, allele G of rs4601728, and allele T of rs12804291 showed a significant association with adiposity. In conclusion, our study identified several MTNR1B variants associated with obesity in the Jackson Heart Study Population. These findings contribute to understanding the link between circadian disruption (insomnia) and metabolic homeostasis.

Methods

Study subject

For this study, we used cross-sectional data from the Jackson Heart Study (JHS). The JHS is a single-site community-based cohort study of risk factors for cardiovascular disease among adult African American men and women living in the Jackson, Mississippi, Metropolitan area. The study participants consisted of 5,306 individuals recruited, interviewed, and examined by certified technicians for the first exam (2000–2004) [29, 30] and were followed up in 2 subsequent exams from 2005 to 2008 and 2009 to 2013. The clinic visits encompassed a physical examination, blood and urine collection, anthropometry, and data collection regarding family history, behavioral risk factors, and sociodemographics. There were 3027 participants (Mean age of 55.13 ± 12.84 and 1871 women) who consented to the genetic analysis, and their DNA samples were genotyped in the candidate gene association resource (CARe) consortium using the Affymetrix 6.0 platform. They were later imputed to 1000 genomes phase 1 [31-33]. The study was approved by the Institutional Review Board (IRB) of the National Institutes of Health. The IRB approved the participating institutions' protocol (University of Mississippi Medical Center, Jackson State University, and Tougaloo College).

Study variables

Outcome variables

Our primary outcome in this study is adiposity (BMI and waist circumference). Adiposity was measured in exam visit 1, and we defined it as a BMI greater than 30 kg/m2 and a waist circumference greater than 102 cm and 88 cm for men and women, respectively. All the above clinical parameters were measured according to standard laboratory and clinical techniques [30].

Independent variables: SNP selection genotyping and imputation

All 3027 JHS samples were genotyped on the Affymetrix 6.0 based on manufacturer protocol [33]. The candidate gene approach was used to select our genetic variants from the entire set of common genetic variants in the MTNR1B gene located on chromosome 11q14.3 and hg19 position base-pair ordinates chr11:92,702,789–92,718,2 (plus-strand orientation). The JHS coordination centers performed the SNPs quality control, and the variants that passed were imputed with 1000G phase 1 using Cosmopolitan reference panel including all races—version 2010–11 data freeze, 2012–03-04 haplotypes [32, 33]. The imputation was completed using Minimac3 on the Michigan Imputation Server [34]; details regarding the reference panel can be found in the 1000 Genomes Project Consortium 2010 [35]. Imputed SNPs were filtered for minor allele frequency ≥ 1%, call rate ≥ 90%, HWE p value > 10–6, as well as the exclusion of sites with invalid or mismatched alleles for the reference panel [32]. For this study, 109 SNPs were genotyped and imputed; we focused on common variants with a minor allele frequency (MAF) ≥ 5%, and with imputation quality ≥ 80%, 30 common variants were selected for downstream analyses. Covariates were age, gender, and 10 principal components to adjust for population stratification due to admixture [17]. In additional analyses, we also adjusted for insomnia covariate. The participants were asked if they have insomnia with the answer option of “Yes,” “No,” and “Don’t Know.” Insomnia is clinically defined as the difficulty of falling and staying asleep [36].

Statistical analysis

Descriptive statistics

The study variables were summarized using the mean and standard deviation (SD) for the continuous variables and proportions for the categorical variables. The continuous variables were first assessed for normality, and then were log-transformed if they were not normally distributed. The analyses for the descriptive statistics were performed using the statistical software SAS® 9.4 [37].

Regression analysis

Multivariate logistic regression models were fitted to assess the associations between the dosage of the MTNR1B genetic variants and adiposity after adjusting for age, gender, and the 10 principal components in the adiposity model. Due to the relationship between melatonin signaling and sleep, we examined the modifying effect of insomnia (adiposity-insomnia model) on our adiposity outcome by stratifying each modifier. Multivariate linear regression models (BMI model and waist circumference model) were fitted to examine the relationships between the MTNR1B genetic variants and the continuous obesity outcome traits of BMI and waist circumference. The linear and logistic regression models were fitted using ProbAbel v.0.5.0 genetic analysis software [38], assuming a population-based design. Although a small subset of the JHS participants belonged to a family component, we did not adjust for family structure because previous studies have shown a minimal impact on power and the inflation of the type I error [39-42]. We used a false discovery rate (FDR) to correct for multiple testing with an adjusted p value threshold of 0.05. The NIH dbSNP database was used to annotate the function of the MTNR1B variants that displayed a significant association using the regression models [43]. The variants that were statistically significant after the FDR adjustment were used to generate a linkage disequilibrium (LD) plot. Haploview (Broad Institute, MA, USA) was used to create the LD plot, and we used the Yoruba, Nigeria population as a reference [44]. Haploview generated the haplotype blocks in the LD plot whenever 95% of the informative comparisons were in strong LD while ignoring variants with an MAF < 0.05 [45].
  41 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  Sleep disorders in African Americans and Caucasian Americans: a meta-analysis.

Authors:  Megan E Ruiter; Jamie DeCoster; Lindsey Jacobs; Kenneth L Lichstein
Journal:  Behav Sleep Med       Date:  2010       Impact factor: 2.964

3.  Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins.

Authors:  L Brydon; F Roka; L Petit; P de Coppet; M Tissot; P Barrett; P J Morgan; C Nanoff; A D Strosberg; R Jockers
Journal:  Mol Endocrinol       Date:  1999-12

4.  Accounting for relatedness in family based genetic association studies.

Authors:  P F McArdle; J R O'Connell; T I Pollin; M Baumgarten; A R Shuldiner; P A Peyser; B D Mitchell
Journal:  Hum Hered       Date:  2007-06-14       Impact factor: 0.444

Review 5.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

6.  Next-generation genotype imputation service and methods.

Authors:  Sayantan Das; Lukas Forer; Sebastian Schönherr; Carlo Sidore; Adam E Locke; Alan Kwong; Scott I Vrieze; Emily Y Chew; Shawn Levy; Matt McGue; David Schlessinger; Dwight Stambolian; Po-Ru Loh; William G Iacono; Anand Swaroop; Laura J Scott; Francesco Cucca; Florian Kronenberg; Michael Boehnke; Gonçalo R Abecasis; Christian Fuchsberger
Journal:  Nat Genet       Date:  2016-08-29       Impact factor: 38.330

Review 7.  Melatonin in type 2 diabetes mellitus and obesity.

Authors:  Angeliki Karamitri; Ralf Jockers
Journal:  Nat Rev Endocrinol       Date:  2019-02       Impact factor: 43.330

Review 8.  RNA binding protein/RNA element interactions and the control of translation.

Authors:  Xavier Pichon; Lindsay A Wilson; Mark Stoneley; Amandine Bastide; Helen A King; Joanna Somers; Anne E E Willis
Journal:  Curr Protein Pept Sci       Date:  2012-06       Impact factor: 3.272

9.  Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin.

Authors:  Ching-Ti Liu; Sridharan Raghavan; Nisa Maruthur; Edmond Kato Kabagambe; Jaeyoung Hong; Maggie C Y Ng; Marie-France Hivert; Yingchang Lu; Ping An; Amy R Bentley; Anne M Drolet; Kyle J Gaulton; Xiuqing Guo; Loren L Armstrong; Marguerite R Irvin; Man Li; Leonard Lipovich; Denis V Rybin; Kent D Taylor; Charles Agyemang; Nicholette D Palmer; Brian E Cade; Wei-Min Chen; Marco Dauriz; Joseph A C Delaney; Todd L Edwards; Daniel S Evans; Michele K Evans; Leslie A Lange; Aaron Leong; Jingmin Liu; Yongmei Liu; Uma Nayak; Sanjay R Patel; Bianca C Porneala; Laura J Rasmussen-Torvik; Marieke B Snijder; Sarah C Stallings; Toshiko Tanaka; Lisa R Yanek; Wei Zhao; Diane M Becker; Lawrence F Bielak; Mary L Biggs; Erwin P Bottinger; Donald W Bowden; Guanjie Chen; Adolfo Correa; David J Couper; Dana C Crawford; Mary Cushman; John D Eicher; Myriam Fornage; Nora Franceschini; Yi-Ping Fu; Mark O Goodarzi; Omri Gottesman; Kazuo Hara; Tamara B Harris; Richard A Jensen; Andrew D Johnson; Min A Jhun; Andrew J Karter; Margaux F Keller; Abel N Kho; Jorge R Kizer; Ronald M Krauss; Carl D Langefeld; Xiaohui Li; Jingling Liang; Simin Liu; William L Lowe; Thomas H Mosley; Kari E North; Jennifer A Pacheco; Patricia A Peyser; Alan L Patrick; Kenneth M Rice; Elizabeth Selvin; Mario Sims; Jennifer A Smith; Salman M Tajuddin; Dhananjay Vaidya; Mary P Wren; Jie Yao; Xiaofeng Zhu; Julie T Ziegler; Joseph M Zmuda; Alan B Zonderman; Aeilko H Zwinderman; Adebowale Adeyemo; Eric Boerwinkle; Luigi Ferrucci; M Geoffrey Hayes; Sharon L R Kardia; Iva Miljkovic; James S Pankow; Charles N Rotimi; Michele M Sale; Lynne E Wagenknecht; Donna K Arnett; Yii-Der Ida Chen; Michael A Nalls; Michael A Province; W H Linda Kao; David S Siscovick; Bruce M Psaty; James G Wilson; Ruth J F Loos; Josée Dupuis; Stephen S Rich; Jose C Florez; Jerome I Rotter; Andrew P Morris; James B Meigs
Journal:  Am J Hum Genet       Date:  2016-06-16       Impact factor: 11.043

10.  Gene-Environment Interactions of Circadian-Related Genes for Cardiometabolic Traits.

Authors:  Hassan S Dashti; Jack L Follis; Caren E Smith; Toshiko Tanaka; Marta Garaulet; Daniel J Gottlieb; Adela Hruby; Paul F Jacques; Jessica C Kiefte-de Jong; Stefania Lamon-Fava; Frank A J L Scheer; Traci M Bartz; Leena Kovanen; Mary K Wojczynski; Alexis C Frazier-Wood; Tarunveer S Ahluwalia; Mia-Maria Perälä; Anna Jonsson; Taulant Muka; Ioanna P Kalafati; Vera Mikkilä; José M Ordovás
Journal:  Diabetes Care       Date:  2015-06-17       Impact factor: 19.112

View more
  1 in total

Review 1.  Circadian disruption and human health.

Authors:  Anna B Fishbein; Kristen L Knutson; Phyllis C Zee
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 19.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.